Herpesviruses: latency and reactivation – viral strategies and host response
暂无分享,去创建一个
[1] B. Roizman,et al. An inquiry into the mechanisms of herpes simplex virus latency. , 1987, Annual review of microbiology.
[2] S. Deshmane,et al. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure , 1989, Journal of virology.
[3] R. L. Thompson,et al. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia , 1992, Journal of virology.
[4] D. Scadden. AIDS-related malignancies. , 1998, Current opinion in oncology.
[5] Daniel L. Feeback,et al. Immune responses and latent herpesvirus reactivation in spaceflight. , 2001, Aviation, space, and environmental medicine.
[6] B. Grinde,et al. Molecular epidemiology of TTV-like mini virus in Norway , 2002, Archives of Virology.
[7] W. Opstelten,et al. Herpes labialis , 2003, Clinical evidence.
[8] P. Barry,et al. B-Virus (Cercopithecine herpesvirus 1) Infection in Humans and Macaques: Potential for Zoonotic Disease , 2003, Emerging infectious diseases.
[9] D. C. Clark. Common acute hand infections. , 2003, American family physician.
[10] Margaret-Mary G. Wilson,et al. Sexually transmitted diseases. , 2003, Clinics in geriatric medicine.
[11] R. Cohrs,et al. Clinical and molecular pathogenesis of varicella virus infection. , 2003, Viral immunology.
[12] G. Pawelec,et al. Is immunosenescence infectious? , 2004, Trends in immunology.
[13] M. Lewis,et al. Herpes simplex virus: an occupational hazard in dentistry. , 2004, International dental journal.
[14] E. Mocarski. Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system , 2004, Cellular microbiology.
[15] A. Wald,et al. A population-based study of primary human herpesvirus 6 infection. , 2005, The New England journal of medicine.
[16] P. Farrell,et al. Reactivation of Epstein‐Barr virus from latency , 2005, Reviews in medical virology.
[17] A. Kubar,et al. Periodontitis lesions are a source of salivary cytomegalovirus and Epstein-Barr virus. , 2005, Journal of periodontal research.
[18] J. Nicholas. Review: Human Gammaherpesvirus Cytokines and Chemokine Receptors , 2005 .
[19] J. Nicholas. Human gammaherpesvirus cytokines and chemokine receptors. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[20] P. Dřevínek,et al. Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[21] Andreas Suhrbier,et al. Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis , 2007, Journal of Virology.
[22] E. Kozlova,et al. Chronic herpesvirus reactivation occurs in aging , 2007, Experimental Gerontology.
[23] G. Klein,et al. Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions , 2007, Oncogene.
[24] A. Vazquez,et al. Epstein–Barr virus and virus human protein interaction maps , 2007, Proceedings of the National Academy of Sciences.
[25] M. Diamond,et al. Herpesvirus latency confers symbiotic protection from bacterial infection , 2007, Nature.
[26] M. Freeman,et al. Psychological Stress Compromises CD8+ T Cell Control of Latent Herpes Simplex Virus Type 1 Infections1 , 2007, The Journal of Immunology.
[27] M. Hricová,et al. Murine gammaherpesvirus 68 serum antibodies in general human population. , 2007, Acta virologica.
[28] O. Cinek,et al. Longitudinal observation of parechovirus in stool samples from Norwegian infants , 2008, Journal of medical virology.
[29] K. Beiske,et al. Human cytomegalovirus and Epstein–Barr virus in apical and marginal periodontitis: A role in pathology? , 2008, Journal of medical virology.
[30] I. Olsen,et al. Patient with severe periodontitis and subgingival Epstein-Barr virus treated with antiviral therapy. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[31] L. Cooper,et al. Induction of Pluripotent Protective Immunity Following Immunisation with a Chimeric Vaccine against Human Cytomegalovirus , 2008, PloS one.
[32] Y. Chida,et al. Does psychosocial stress predict symptomatic herpes simplex virus recurrence? A meta-analytic investigation on prospective studies , 2009, Brain, Behavior, and Immunity.
[33] B. Cullen,et al. Viruses, microRNAs, and host interactions. , 2010, Annual review of microbiology.
[34] G. Pawelec,et al. Senescence of the human immune system. , 2010, Journal of comparative pathology.
[35] A. Froment,et al. Frequent and Recent Human Acquisition of Simian Foamy Viruses Through Apes' Bites in Central Africa , 2011, PLoS pathogens.
[36] H. Agut,et al. Herpes simplex encephalitis : from virus to therapy. , 2011, Infectious disorders drug targets.
[37] D. Lindemann,et al. Foamy Virus Biology and Its Application for Vector Development , 2011, Viruses.
[38] H. Balfour,et al. Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections , 2011, Clinical Microbiology Reviews.
[39] R. Hendricks,et al. CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation , 2011, Journal of NeuroVirology.
[40] Marco Y. Hein,et al. Decoding Human Cytomegalovirus , 2012, Science.
[41] I. Mohr,et al. A cultured affair: HSV latency and reactivation in neurons. , 2012, Trends in microbiology.
[42] Asim V. Farooq,et al. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. , 2012, Survey of ophthalmology.
[43] R. Beigi. Sexually Transmitted Diseases: Beigi/Sexually Transmitted Diseases , 2012 .
[44] I. Mohr,et al. Control of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressor. , 2012, Genes & development.
[45] W. Hammerschmidt,et al. The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination , 2012, PLoS pathogens.
[46] M. Ryder,et al. Periodontal disease in HIV/AIDS. , 2012, Periodontology 2000.
[47] A. Osterhaus,et al. Longitudinal study on oral shedding of herpes simplex virus 1 and varicella‐zoster virus in individuals infected with HIV , 2013, Journal of medical virology.
[48] G. Rimmelzwaan,et al. Clearance of influenza virus infections by T cells: risk of collateral damage? , 2013, Current opinion in virology.
[49] C. Evans,et al. Management of herpesvirus infections. , 2013, International journal of antimicrobial agents.
[50] M. Forsgren,et al. Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] D. Shukla,et al. Recent advances in vaccine development for herpes simplex virus types I and II , 2013, Human vaccines & immunotherapeutics.
[52] J. Fishman. Overview: Cytomegalovirus and the Herpesviruses in Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[53] J. Nelson,et al. Functional genomics approaches to understand cytomegalovirus replication, latency and pathogenesis. , 2013, Current opinion in virology.